Chemoenzymatic ligation comes of age: A present-day solution for scalable manufacturing for siRNA and sgRNA drugs
As the market demand for RNA therapeutics such as siRNA and sgRNA is anticipated to grow substantially over the next decade, there is a need for scalable, cost-effective, and sustainable...
